American National Bank & Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Hold
26,998
0.3% 54
2026
Q1
$3.25M Sell
26,998
-2,726
-9% -$315K 0.31% 56
2025
Q4
$3.13M Buy
29,724
+3,744
+14% +$351K 0.3% 57
2025
Q3
$2.18M Sell
25,980
-1,207
-4% -$99.4K 0.22% 64
2025
Q2
$2.15M Buy
27,187
+3,965
+17% +$315K 0.22% 62
2025
Q1
$2.08M Sell
23,222
-5,638
-20% -$526K 0.23% 61
2024
Q4
$2.87M Sell
28,860
-367
-1% -$37.8K 0.32% 59
2024
Q3
$3.32M Sell
29,227
-565
-2% -$67.1K 0.39% 54
2024
Q2
$3.69M Sell
29,792
-23
-0.1% -$2.96K 0.46% 50
2024
Q1
$3.93M Sell
29,815
-1,072
-3% -$132K 0.52% 50
2023
Q4
$3.37M Buy
30,887
+8,152
+36% +$846K 0.53% 50
2023
Q3
$2.34M Buy
22,735
+2,388
+12% +$257K 0.4% 58
2023
Q2
$2.35M Buy
20,347
+6,841
+51% +$777K 0.4% 50
2023
Q1
$1.44M Buy
13,506
+1,579
+13% +$170K 0.27% 63
2022
Q4
$1.32M Buy
11,927
+2,053
+21% +$210K 0.27% 64
2022
Q3
$850K Buy
9,874
+990
+11% +$88.4K 0.2% 79
2022
Q2
$810K Buy
8,884
+664
+8% +$58.9K 0.19% 78
2022
Q1
$674K Sell
8,220
-1,070
-12% -$84.4K 0.13% 89
2021
Q4
$712K Sell
9,290
-9,577
-51% -$763K 0.14% 83
2021
Q3
$1.42M Buy
18,867
+830
+5% +$63.1K 0.31% 64
2021
Q2
$1.4M Buy
18,037
+8,872
+97% +$660K 0.3% 61
2021
Q1
$674K Buy
9,165
+6,155
+204% +$454K 0.16% 80
2020
Q4
$235K Buy
3,010
+658
+28% +$50.3K 0.06% 91
2020
Q3
$186K Sell
2,352
-209
-8% -$16.4K 0.05% 92
2020
Q2
$189K Sell
2,561
-210
-8% -$15.8K 0.06% 90
2020
Q1
$203K Buy
2,771
+1,933
+231% +$152K 0.08% 90
2019
Q4
$73K Hold
838
0.02% 110
2019
Q3
$67K Buy
+838
New +$67.2K 0.02% 114
2019
Q1
Sell
-7,132
Closed -$520K 164
2018
Q4
$520K Buy
7,132
+74
+1% +$5.22K 0.19% 67
2018
Q3
$478K Buy
7,058
+298
+4% +$19K 0.14% 83
2018
Q2
$392K Sell
6,760
-1,767
-21% -$99.7K 0.11% 99
2018
Q1
$443K Sell
8,527
-286
-3% -$15.4K 0.13% 90
2017
Q4
$473K Buy
8,813
+1,894
+27% +$105K 0.13% 88
2017
Q3
$423K Buy
6,919
+561
+9% +$34K 0.13% 90
2017
Q2
$389K Buy
6,358
+252
+4% +$15.3K 0.12% 83
2017
Q1
$370K Buy
6,106
+64
+1% +$3.88K 0.12% 85
2016
Q4
$339K Buy
6,042
+1,640
+37% +$96K 0.11% 83
2016
Q3
$262K Hold
4,402
0.09% 85
2016
Q2
$242K Hold
4,402
0.09% 86
2016
Q1
$222K Sell
4,402
-384
-8% -$18.8K 0.08% 82
2015
Q4
$241K Sell
4,786
-412
-8% -$20.8K 0.09% 78
2015
Q3
$245K Buy
5,198
+360
+7% +$19.1K 0.1% 82
2015
Q2
$263K Hold
4,838
0.11% 74
2015
Q1
$265K Sell
4,838
-402
-8% -$22.8K 0.1% 77
2014
Q4
$284K Hold
5,240
0.11% 81
2014
Q3
$296K Hold
5,240
0.11% 78
2014
Q2
$289K Hold
5,240
0.11% 83
2014
Q1
$284K Buy
5,240
+210
+4% +$10.9K 0.11% 79
2013
Q4
$240K Hold
5,030
0.1% 79
2013
Q3
$228K Hold
5,030
0.1% 80
2013
Q2
$223K Buy
+5,030
New +$225K 0.1% 78

Other funds holding MRK

American National Bank & Trust's MRK Position: Q2 2026 in Review

American National Bank & Trust held its Merck (MRK) position steady in Q2 2026 at 26,998 shares worth $3.47M. The position accounts for 0.3% of the portfolio, ranked #54.

American National Bank & Trust first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.93M in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • American National Bank & Trust held 26,998 shares of Merck worth $3.47M as of Q2 2026.
  • American National Bank & Trust left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.3% of American National Bank & Trust's portfolio in Q2 2026, its #54 holding.
  • American National Bank & Trust first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • American National Bank & Trust's Merck position peaked at $3.93M in Q1 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.